Vertex Pharmaceuticals' Revenue Forecast Tops Expectations
Vertex Pharmaceuticals ( VRTX) reported fourth-quarter revenue and offered an outlook for 2025 that topped analysts’ expectations. The company said it anticipates 2025 revenue of $11.75 billion to $12 ...
ETF Daily News1mon
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut to $533.00 by Analysts at Piper Sandler
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its target price dropped by Piper Sandler from $535.00 to $533.00 in a report released on Monday,Benzinga reports. The firm currently h ...